Alternatives to Janux Therapeutics

Biopharmaceutical company developing T-cell therapies for solid tumor cancers.

Biotechnology company developing and commercializing cell therapies for cancer treatment.

Biopharmaceutical company developing antibody-based therapeutics for cancer and autoimmune diseases.

A global biotechnology company discovering, developing, manufacturing, and delivering innovative human therapeutics.

Develops, manufactures, and markets radiopharmaceuticals for diagnostic and therapeutic applications.

Global biopharmaceutical company focused on oncology and neuroscience treatments.

A biotechnology company that invents, develops, manufactures, and commercializes medicines for serious diseases.

Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.

Biomica is developing a novel microbiome-based platform for the treatment of cancer.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Global biopharmaceutical company pioneering mRNA-based immunotherapies and vaccines for cancer and infectious diseases.

Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).

A life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.

Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.

Freenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.

A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.

Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.

Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.

Developing first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.

Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).